Leviticus-Cardio

Leviticus-Cardio is a medical device company based in Israel, founded in 2008. The company specializes in advanced wireless power transfer technologies for patients with Congestive Heart Failure (CHF). Its innovative solutions aim to improve clinical outcomes for those requiring implanted cardiac support devices by eliminating traditional wired power connections. The core technology of Leviticus-Cardio is the proprietary transcutaneous Coplanar Energy Transfer (CET) system, which enables wireless power delivery to implanted left ventricular assist devices (LVADs). This technology enhances patient mobility and reduces infection risks by avoiding physical driveline cables. One of its key products is the FIVAD system, developed in collaboration with Jarvik Heart. This fully implanted ventricular assist device allows patients to move freely for up to eight hours a day without the constraints of power cables. Leviticus-Cardio focuses on wireless power transfer solutions, the development of advanced energy transfer systems, and collaborative medical device innovation. The company has demonstrated the safety and efficacy of its technology through extensive studies and has gained recognition in the medical community.

• Employees 3
• Founded 2008
• Annual Revenue $49217000
• Total Funding $5500000